Back to Authors

Yen, Shu‐Hui

A5111947017 | I4210146710

Mayo Clinic

Mayo Clinic in Florida

Citations 15

P1‐371: Characteristics of cytosolic hyperphosphorylated tau species in rTg4510 mouse brain

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_9 | Pages: No page available

10.1016/j.jalz.2010.05.925

P1‐165: Generation and characterization of FTLD‐U and ALS cell model with inducible expression of TDP‐43 C‐terminal fragment

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2010.05.715

Using leucine zipper to facilitate α‐synuclein assembly

The FASEB Journal | May 20, 2008 | Volume: 22 | Issue: 9 | Pages: 3165-3174

10.1096/fj.08-108365 | PMID 18492724

ABSTRACT The accumulation of filamentous a‐synuclein (α‐S) is associated with Parkinson's disease. It remains controversial as to the mode (antiparallel or parallel) of α‐S self‐assembly and whether an exact alignment of the central hydrophobic region is essential. In the present study, we performed in vitro assembly using α‐S with or without the attachment of artificial leucine zippers (Zips) capable of forming either parallel or antiparallel coiled coils and included a spacer in one derivative. Results showed that Zips accelerate filament assembly in both the parallel and antiparallel fashions, that a precise alignment of the central hydrophobic region is not essential, and that the antiparallel pairs displayed the highest thioflavin T signals. More importantly, cells expressing Zip‐fused α‐S, but not α‐S alone, formed α‐S immunopositive and thioflavin S‐positive inclusions in 7 days. The results suggest that α‐S can assemble in both parallel and antiparallel modes but have a higher tendency to assemble in the latter mode and that cells overexpressing Zip‐fused α‐S may be used to screen α‐S assembly inhibitors due to enhanced ability to form inclusions.—Jiang, P., Ko, L., Jansen, K. R., Golde, T. E., Yen, S.‐H. Using leucine zipper to facilitate α‐synuclein assembly. FASEB J. 22, 3165–3174 (2008)
P2–049: Effect of proteasomal inhibitors on tau truncation and aggregation in a cellular model of tauopathy

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_8 | Pages: No page available

10.1016/j.jalz.2006.05.886

Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP

Science | July 27, 2002 | Volume: 293 | Issue: 5534 | Pages: 1487-1491

10.1126/science.1058189 | PMID 11520987

JNPL3 transgenic mice expressing a mutant tau protein, which develop neurofibrillary tangles and progressive motor disturbance, were crossed with Tg2576 transgenic mice expressing mutant β-amyloid precursor protein (APP), thus modulating the APP-Aβ (β-amyloid peptide) environment. The resulting double mutant (tau/APP) progeny and the Tg2576 parental strain developed Aβ deposits at the same age; however, relative to JNPL3 mice, the double mutants exhibited neurofibrillary tangle pathology that was substantially enhanced in the limbic system and olfactory cortex. These results indicate that either APP or Aβ influences the formation of neurofibrillary tangles. The interaction between Aβ and tau pathologies in these mice supports the hypothesis that a similar interaction occurs in Alzheimer's disease.